Eric Patzer
Founder chez ARIDIS PHARMACEUTICALS, INC.
Fortune : 54 766 $ au 31/03/2024
Profil
Eric J.
Patzer is the founder of Aridis Pharmaceuticals, Inc. (founded in 2003) and holds the title of Executive Chairman.
He is currently a Director at FluGen, Inc. and Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Eric's former positions include Vice President-Development at Genentech, Inc. (1981-1996), MedImmune Vaccines, Inc. (1996-2002), and Aviron, Inc. (Pennsylvania) (1996-2002).
He obtained a doctorate degree from the University of Virginia and an undergraduate degree from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
02/11/2023 | 702 132 ( 1,58% ) | 54 766 $ | 31/03/2024 |
Postes actifs de Eric Patzer
Sociétés | Poste | Début |
---|---|---|
ARIDIS PHARMACEUTICALS, INC. | Founder | 01/01/2003 |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Director/Board Member | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Director/Board Member | - |
Anciens postes connus de Eric Patzer
Sociétés | Poste | Fin |
---|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | 01/01/2002 |
Aviron, Inc. (Pennsylvania) | Corporate Officer/Principal | 01/01/2002 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1996 |
Formation de Eric Patzer
University of Virginia | Doctorate Degree |
The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ARIDIS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Health Technology |
Aviron, Inc. (Pennsylvania) | |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. |